Dogwood Selling General Administrative vs Total Current Liabilities Analysis
| DWTX Stock | 2.40 0.20 7.69% |
Dogwood Therapeutics, financial indicator trend analysis is much more than just examining Dogwood Therapeutics, latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dogwood Therapeutics, is a good investment. Please check the relationship between Dogwood Therapeutics, Selling General Administrative and its Total Current Liabilities accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dogwood Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Dogwood Stock please use our How to Invest in Dogwood Therapeutics, guide.
Selling General Administrative vs Total Current Liabilities
Selling General Administrative vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dogwood Therapeutics, Selling General Administrative account and Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Dogwood Therapeutics,'s Selling General Administrative and Total Current Liabilities is 0.87. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Dogwood Therapeutics,, assuming nothing else is changed. The correlation between historical values of Dogwood Therapeutics,'s Selling General Administrative and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Dogwood Therapeutics, are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Selling General Administrative i.e., Dogwood Therapeutics,'s Selling General Administrative and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.87 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Selling General Administrative
Total Current Liabilities
Total Current Liabilities is an item on Dogwood Therapeutics, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dogwood Therapeutics, are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Dogwood Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dogwood Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dogwood Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Dogwood Stock please use our How to Invest in Dogwood Therapeutics, guide.Selling General Administrative is likely to rise to about 4.5 M in 2024
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 15.6M | 12.3M | 5.4M | 8.7M | Research Development | 10.8M | 8.1M | 1.7M | 1.6M |
Dogwood Therapeutics, fundamental ratios Correlations
Click cells to compare fundamentals
Dogwood Therapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.